Premier Biomedical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Revenue	0.01	0.04	0.04	-	-
Revenue Growth (YoY)	-64.11%	0.09%	-	-	-
Cost of Revenue	0.01	0.11	0.03	-	-
Gross Profit	0	-0.07	0.01	-	-
Selling, General & Admin	0.33	0.62	1.12	0.52	2.15
Research & Development	-	-	0.18	0.11	0.23
Operating Expenses	0.33	0.62	1.3	0.64	2.38
Operating Income	-0.33	-0.69	-1.29	-0.64	-2.38
Interest Expense	-0.39	-0.42	-0.35	-0.82	-0.2
Earnings From Equity Investments	-	-	-0.01	-	-
Other Non Operating Income (Expenses)	0.34	0.7	-2.12	-0.37	-0.02
EBT Excluding Unusual Items	-0.37	-0.41	-3.76	-1.82	-2.6
Other Unusual Items	-	0.01	-	0.05	-
Pretax Income	-0.37	-0.4	-3.76	-1.77	-2.6
Net Income	-0.37	-0.4	-3.76	-1.77	-2.6
Net Income to Common	-0.37	-0.4	-3.76	-1.77	-2.6
Shares Outstanding (Basic)	52	4	2	1	0
Shares Outstanding (Diluted)	52	4	2	1	0
Shares Change (YoY)	1394.89%	78.97%	222.90%	385.06%	53.19%
EPS (Basic)	-0.01	-0.11	-1.92	-2.91	-20.80
EPS (Diluted)	-0.01	-0.11	-1.92	-2.91	-20.80
Free Cash Flow	-0.35	-0.45	-0.51	-0.49	-0.46
Free Cash Flow Per Share	-0.01	-0.13	-0.26	-0.80	-3.70
Gross Margin	9.95%	-185.78%	36.02%	-	-
Operating Margin	-2287.90%	-1741.03%	-3243.98%	-	-
Profit Margin	-2622.16%	-1002.35%	-9465.45%	-	-
Free Cash Flow Margin	-2444.02%	-1123.02%	-1282.19%	-	-
EBITDA	-0.32	-0.69	-1.29	-0.64	-2.38
D&A For EBITDA	0	0	0	0	0
EBIT	-0.33	-0.69	-1.29	-0.64	-2.38
Advertising Expenses	0.05	0.07	0.06	0.08	0.06

Updated May 15, 2020. Source: S&P Global Market Intelligence. Standard template. Financial Sources.